New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a ‘Form 483’ with three observations to its manufacturing facility in Somerset, New Jersey, following a recent inspection.In a regulatory filing, the pharmaceutical company said that the inspection by the US Food and Drug Administration (USFDA) was conducted this week between April 13 and April 17.”The inspection was completed with the issuance of a Form 483 carrying three observations,” th…
Trending
- Mathe Male Hoyyuthide Review: A Heartfelt Generational Love Story Set in the Rains of Malenadu
- M4M – Motive for Murder Review: A Gripping Telugu Crime Thriller That Turns Murders into Masterpieces
- Ankam Attahasam Movie Review (2026): Madhav Suresh’s Gritty Trivandrum Gangster Drama Is a Raw, Riveting Ride
- Citadel Season 2 Review (2026): Priyanka Chopra, Richard Madden & Stanley Tucci Make This Prime Video Thriller Unmissable
- Dridam Movie Review: Shane Nigam’s Slow-Burn Cop Drama Is Gripping — Until It Isn’t
- 29 Movie Review: A Heartfelt Romantic Drama That Blooms in Its Own Time
- Razor Movie Review (2026): Ravi Babu Delivers a Gripping Survival Thriller
- Sathi Leelavathi Review (2026): Lavanya Tripathi Shines in This Heartfelt Family Entertainer